Presentation of Leishmania donovani promastigotes occurs via a brefeldin A‐sensitive pathway
- 1 October 1991
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 21 (10) , 2407-2413
- https://doi.org/10.1002/eji.1830211017
Abstract
For the presentation of Leishmania promastigotes to polyclonal CD4+ T cells, a processing period within activated macrophages of 3–4 h is required. Presentation can be inhibited by both chloroquine and brefeldin A (BFA), the latter implicating a requirement for newly synthesized MHC class II molecules. This inhibition is both reversible and specific, in that BFA did not inhibit mixed lymphocyte reaction stimulation by these infected macrophages. Immunogold labeling demonstrated that class II was associated with the parasite-containing phagolysosome. The level of class II was not significantly altered in BFA-treated cells in the time period studied, suggesting that antigen may exist the phagolysosome and interact with class II in another cellular compartment.Keywords
This publication has 50 references indexed in Scilit:
- Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartmentsNature, 1991
- A coat subunit of Golgi-derived non-clathrin-coated vesicles with homology to the clathrin-coated vesicle coat protein β-adaptinNature, 1991
- The function of the invariant chain in antigen presentation by MHC class II moleculesImmunology Today, 1990
- Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathwaysNature, 1990
- Inhibition by brefeldin A of presentation of exogenous protein antigens to MHC class II-restricted T cellsNature, 1990
- The costimulatory function of antigen-presenting cellsImmunology Today, 1990
- Rapid redistribution of Golgi proteins into the ER in cells treated with brefeldin A: Evidence for membrane cycling from Golgi to ERCell, 1989
- Antigen presentation and the response to parasitic infectionParasitology Today, 1987
- F4/80, a monoclonal antibody directed specifically against the mouse macrophageEuropean Journal of Immunology, 1981
- Fusion of Host Cell Secondary Lysosomes with the Parasitophorous Vacuoles of Leishmania mexicana‐inlected MacrophagesThe Journal of Protozoology, 1975